600763.SS SHH
Topchoice Medical Corporation
1W: +1.0%
1M: -1.2%
3M: -3.7%
YTD: -29.9%
1Y: -24.8%
3Y: -52.5%
5Y: -86.5%
¥34.07 ($5.08)
+1.07 (+3.24%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$763M
-9.1% ▼
5Y CAGR: +3.3%
Capital Expenditures
$332M
+34.7% ▲
5Y CAGR: +21.4%
Free Cash Flow
$431M
+28.9% ▲
5Y CAGR: -3.7%
Dividends Paid
$150M
-1233.4% ▼
Buybacks
$30M
-2896.1% ▼
Net Change in Cash
$26M
+172.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $545M | $786M | $616M | $500M | $572M |
| Depreciation & Amort. | $63M | $154M | $173M | $189M | $203M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $91M | -$5M | -$178M | $23M | -$72M |
| Other Non-Cash Items | $10M | $5M | $59M | $135M | $59M |
| Operating Cash Flow | $708M | $939M | $670M | $840M | $763M |
| — Investing Activities — | |||||
| Capital Expenditures | -$170M | -$367M | -$422M | -$509M | -$332M |
| Acquisitions (Net) | -$65M | $132M | $37M | $0 | -$28M |
| Investment Purchases | $5M | -$143M | -$100M | -$510M | -$27M |
| Investment Sales | $28M | $33M | $65M | $6M | $25M |
| Other Investing | -$91M | -$138M | -$78M | $129M | $37M |
| Investing Cash Flow | -$294M | -$484M | -$497M | -$884M | -$325M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$100M | -$105M | -$110M | $238M | -$39M |
| Stock Repurchased | $0 | $0 | -$100M | -$1M | -$30M |
| Dividends Paid | -$21M | -$13M | -$7M | -$11M | -$150M |
| Other Financing | -$115M | -$168M | -$269M | -$218M | -$194M |
| Financing Cash Flow | -$236M | -$286M | -$386M | $9M | -$413M |
| Net Change in Cash | $178M | $170M | -$213M | -$35M | $26M |
| Cash End of Period | $673M | $843M | $630M | $594M | $620M |
| Free Cash Flow | $538M | $572M | $249M | $335M | $431M |